Denali Therapeutics Inc (DNLI)
15.59
-0.50
(-3.11%)
USD |
NASDAQ |
Apr 24, 15:57
Denali Therapeutics Total Assets (Quarterly): 1.154B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.154B |
| September 30, 2023 | 1.237B |
| June 30, 2023 | 1.306B |
| March 31, 2023 | 1.409B |
| December 31, 2022 | 1.460B |
| September 30, 2022 | 1.228B |
| June 30, 2022 | 1.292B |
| March 31, 2022 | 1.321B |
| December 31, 2021 | 1.404B |
| September 30, 2021 | 1.450B |
| June 30, 2021 | 1.510B |
| March 31, 2021 | 1.548B |
| December 31, 2020 | 1.604B |
| September 30, 2020 | 1.070B |
| Date | Value |
|---|---|
| June 30, 2020 | 647.34M |
| March 31, 2020 | 695.86M |
| December 31, 2019 | 553.23M |
| September 30, 2019 | 602.98M |
| June 30, 2019 | 637.60M |
| March 31, 2019 | 676.60M |
| December 31, 2018 | 661.98M |
| September 30, 2018 | 544.48M |
| June 30, 2018 | 572.06M |
| March 31, 2018 | 613.95M |
| December 31, 2017 | 486.72M |
| September 30, 2017 | 210.31M |
| December 31, 2016 | 271.07M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
553.23M
Minimum
Dec 2019
1.604B
Maximum
Dec 2020
1.165B
Average
1.292B
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Halozyme Therapeutics Inc | 1.733B |
| AIM ImmunoTech Inc | 19.38M |
| Perspective Therapeutics Inc | 97.89M |
| Protalix BioTherapeutics Inc | 84.43M |
| Armata Pharmaceuticals Inc | 98.36M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 122.96M |
| Shareholders Equity (Quarterly) | 1.031B |